Jan Rekowski

Targeting the p300/CBP Axis in Lethal Prostate Cancer

Jonathan Welti, Adam Sharp, Nigel Brooks et al. · Cancer Discovery · 2021 · 269 citations · Full text

Positron Emission Tomography–Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL): A Multicenter, Randomized Phase III Trial

Ulrich Dührsen, Stefan Müller, Bernd Hertenstein et al. · Journal of Clinical Oncology · 2018 · 238 citations

Biomarkers Associating with PARP Inhibitor Benefit in Prostate Cancer in the TOPARP-B Trial

Suzanne Carreira, Núria Porta, Sara Arce‐Gallego et al. · Cancer Discovery · 2021 · 157 citations · Full text

Advanced Prostate Cancer with ATM Loss: PARP and ATR Inhibitors

Antje Neeb, Nicolás Herranz, Sara Arce‐Gallego et al. · European Urology · 2020 · 114 citations · Full text

Eculizumab in cold agglutinin disease (DECADE): an open-label, prospective, bicentric, nonrandomized phase 2 trial

Alexander Röth, Martin Bommer, Andreas Hüttmann et al. · Blood Advances · 2018 · 108 citations · Full text

Immunohematology, Immunodeficiencies, Immunology +16